Osaka University · Research Institute for Microbial Diseases

Research keywordsmalaria vaccines・RTS,S・blood-stage vaccine・SE36 antigen・Plasmodium falciparum・vaccine immunogenicity・asymptomatic parasitemia・apicoplast genome

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• RH5.1/Matrix-M: highlighting blood-stage malaria vaccines.2025 · The Lancet. Infectious diseases Vol. 25 No. 5 p. 472-473 2025年5月1日 研究論文（学術雑誌）
• Understanding the immunogenicity of RTS,S in infants.2025 · The Lancet. Infectious diseases Vol. 25 No. 3 p. 253-255 2025年3月1日 研究論文（学術雑誌）
• Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5-10-Year-Old Burkinabe Children Naturally Exposed to Malaria.2024 · Vaccines Vol. 12 No. 2 p. 166-166 2024年2月6日 研究論文（学術雑誌）
• Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism.2024 · Parasitology international Vol. 99 p. 102845-102845 2024年4月1日 研究論文（学術雑誌）

• Official profile